SCHEMBL7219197

SCHEMBL7219197

COc1cccc2c(C(O)c3ccsc3)cc(C(F)(F)F)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 7/20 0.46
ADORA1 P30542 6/20 0.46
KCNH2 Q12809 8/20 0.39
CYP3A4 P08684 4/20 0.39
KDM4E B2RXH2 4/20 0.39
ADORA3 P0DMS8 2/20 0.39
TSHR P16473 2/20 0.39
CYP2D6 P10635 2/20 0.39
ADORA2B P29275 1/20 0.39
CYP2C19 P33261 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
NR1I2 O75469 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
HTR1A P08908 1/20 0.39
CNR1 P21554 1/20 0.39
GLRA1 P23415 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2A P28223 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7219832 0.87 KCNH2 (0.51) ADORA2AADORA1KCNH2CYP3A4KDM4E
SCHEMBL7219566 0.86 ADORA2A (0.48) ADORA2AADORA1KCNH2CYP3A4KDM4E
SCHEMBL7225014 0.85 ADORA2A (0.63) ADORA2AADORA1KCNH2CYP3A4KDM4E
SCHEMBL7227499 0.84 ADORA2A (0.49) ADORA2AADORA1KCNH2CYP3A4KDM4E
SCHEMBL7220936 0.84 ADORA2A (0.48) ADORA2AADORA1KCNH2CYP3A4KDM4E
SCHEMBL7227085 0.83 ADORA2A (0.46) ADORA2AADORA1KCNH2CYP3A4KDM4E
SCHEMBL7221381 0.78 ADORA2A (0.74) ADORA2AADORA1KMT2A
SCHEMBL19149168 0.78 TNKS (0.43) ADORA2AADORA1KCNH2CYP3A4KDM4E
SCHEMBL7225190 0.77 KCNH2 (0.52) ADORA2AADORA1KCNH2CYP3A4KDM4E
SCHEMBL3952773 0.73 TNKS (0.47) ADORA2AKDM4ETSHRLMNAHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583156-B1 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol VERNALIS RESEARCH LIMITED (GB) 2003-06-24 US disclosed